Toggle Main Menu Toggle Search

ePrints

A phase 2 proof of concept study of MBX-8025 in patients with Primary Biliary Cholangitis (PBC) who are inadequate responders to ursodeoxycholic acid (UDCA)

Lookup NU author(s): Professor David Jones

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Jones D, Galambos MR, Swain MG, Doerffel Y, Steinberg A, Varga M, Choi YJ, Martin R, McWherter C, Chera H, Boudes P, Hirschfield GM

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: The Liver Meeting AASLD 2016

Year of Conference: 2016

Pages: 1123A-1124A

Print publication date: 01/12/2016

Online publication date: 18/11/2016

Acceptance date: 02/04/2016

ISSN: 0270-9139

Publisher: John Wiley & Sons, Inc.

URL: https://doi.org/10.1002/hep.28909

DOI: 10.1002/hep.28909

Series Title: Hepatology


Actions

    Link to this publication


Share